Schedule 13G ownership disclosure

Idera Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 45168K405

Event date: 2020-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
12.0000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-21-009426
Form type
SC 13G/A
Filer
BAKER BROS. ADVISORS LP
CIK
CIK 1263508
Filed
Jan 29, 2021
Reporting period
Dec 31, 2020
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub